Product Name	eIF2B1
Chinese Name	eIF2B1蛋白抗体
Alias	26kDa; D5Ertd406e; EI2BA; eIF 2a; EIF 2B; eIF 2B GDP GTP exchange factor subunit alpha; EIF 2Balpha; EIF2B alpha; EIF2B; EIF2B1; EIF2BA; eukaryotic translation initiation factor 2B subunit 1 alpha; Eukaryotic translation initiation factor 2B, alpha; eukaryotic translation initiation factor 2B, subunit 1 (alpha, 26kD); Eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa; MGC117409; MGC125868; EI2BA_HUMAN; MGC125869; MGC6458; Translation initiation factor eIF2B subunit alpha; zgc:86660.
Research Area	Neurobiology Signal transduction Epigenetics
Immunogen Species	Rabbit
Clonality	Polyclonal
React Species	Mouse(predicted:Human,Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit,Sheep)
Applications	WB=1:500-2000 （Paraffin sections need antigen repair） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.
Theoretical molecular weight	34kDa
Cellular localization	cytoplasmic
Form	Liquid
Concentration	1mg/ml
immunogen	KLH conjugated synthetic peptide derived from human eIF2B1: 51-150/305
Lsotype	IgG
Purification	affinity purified by Protein A
Buffer Solution	1M TBS(pH7.4) with 1% BSA, 3% Proclin300 and 50% Glycerol.
Storage	Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
Attention	This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed	PubMed
Product Detail	This gene encodes one of five subunits of eukaryotic translation initiation factor 2B (EIF2B), a GTP exchange factor for eukaryotic initiation factor 2 and an essential regulator for protein synthesis. Mutations in this gene and the genes encoding other EIF2B subunits have been associated with leukoencephalopathy with vanishing white matter. [provided by RefSeq, Oct 2009] Function: eIF2B1 is one of five subunits of eukaryotic translation initiation factor 2B (EIF2B), a GTP exchange factor for eukaryotic initiation factor 2 and an essential regulator for protein synthesis. Mutations in this gene and the genes encoding other EIF2B subunits have been associated with leukoencephalopathy with vanishing white matter. Subunit: Complex of five different subunits; alpha, beta, gamma, delta and epsilon. Subcellular Location: Plasma membrane DISEASE: Leukodystrophy with vanishing white matter (VWM) [MIM:603896]: A leukodystrophy that occurs mainly in children. Neurological signs include progressive cerebellar ataxia, spasticity, inconstant optic atrophy and relatively preserved mental abilities. The disease is chronic-progressive with, in most individuals, additional episodes of rapid deterioration following febrile infections or minor head trauma. While childhood onset is the most common form of the disorder, some severe forms are apparent at birth. A severe, early-onset form seen among the Cree and Chippewayan populations of Quebec and Manitoba is called Cree leukoencephalopathy. Milder forms may not become evident until adolescence or adulthood. Some females with milder forms of the disease who survive to adolescence exhibit ovarian dysfunction. This variant of the disorder is called ovarioleukodystrophy. Note=The disease is caused by mutations affecting the gene represented in this entry. Similarity: Belongs to the eIF-2B alpha/beta/delta subunits SWISS: Q14232 Gene ID: 1967 Database links: Entrez Gene: 1967 Human Entrez Gene: 209354 Mouse Entrez Gene: 64514 Rat Omim: 606686 Human SwissProt: Q14232 Human SwissProt: Q99LC8 Mouse SwissProt: Q64270 Rat
Product Picture	Sample: Liver (Mouse) Lysate at 40 ug Primary: Anti-eIF2B1   (SL14535R) at 1/500 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 34 kD Observed band size: 34 kD